Default company panoramic image

Replicor Inc.

Developing the cure for 400 million patients with chronic hepatitis B

  • Stage Concept Only
  • Industry Biotechnology
  • Location Montreal, QC, Canada
  • Currency USD
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.